Evidence map›Paper›PMID 39931443›Full record

ArticleChina CDC weekly2025

Characterization of

Ying Li, Keyi Yu, Xiaoli Du, Yuwei Liu, Aixia Yan, Miao Wang, Ying Kang, Shoufei Li, Yuanyuan Wang, Luotong Wang and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Genomic insights intoFrontiers in microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ying LiShunyi District Center for Disease Control and Prevention, Beijing, China.
Keyi YuZhejiang Province Center for Disease Control and Prevention, Hangzhou City, Zhejiang Province, China.
Xiaoli DuNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Yuwei LiuShunyi District Center for Disease Control and Prevention, Beijing, China.
Aixia YanShunyi District Center for Disease Control and Prevention, Beijing, China.
Miao WangShunyi District Center for Disease Control and Prevention, Beijing, China.
Ying KangShunyi District Center for Disease Control and Prevention, Beijing, China.
Shoufei LiShunyi District Center for Disease Control and Prevention, Beijing, China.
Yuanyuan WangShunyi District Center for Disease Control and Prevention, Beijing, China.
Luotong WangShunyi District Center for Disease Control and Prevention, Beijing, China.
Shengtian LiuShunyi District Center for Disease Control and Prevention, Beijing, China.
Tao PengShunyi District Center for Disease Control and Prevention, Beijing, China.
Jun LiMicrobiological Laboratory, Hangzhou Center for Disease Control and Prevention (Hangzhou Health Supervision Institution), Hangzhou City, Zhejiang Province, China.
Duochun WangNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Zhenzhou HuangMicrobiological Laboratory, Hangzhou Center for Disease Control and Prevention (Hangzhou Health Supervision Institution), Hangzhou City, Zhejiang Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: Results: In total, 38 Conclusions: This study provides valuable insights into the prevalence and characteristics of

Indexed as

AeromonasAntibiotic resistanceDiarrheaWhole genome sequencing

Identifiers

PMID39931443
PMCPMC11807246

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.